[HTML] thelancet.comFull View

[HTML][HTML] Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: a cohort study in UK Biobank

Q Wang, V Codd, Z Raisi-Estabragh, C Musicha… - …, 2021 - thelancet.com
Background Older age is the most powerful risk factor for adverse coronavirus disease-19
(COVID-19) outcomes. It is uncertain whether leucocyte telomere length (LTL), previously …
被引用次数：39 相关文章

Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank.

Q Wang, V Codd, Z Raisi-Estabragh, C Musicha… - 2021 - repository.cam.ac.uk
Background Older age is the most powerful risk factor for adverse coronavirus disease-19
(COVID-19) outcomes. It is uncertain whether leucocyte telomere length (LTL), previously …
[PDF] qmul.ac.uk

[PDF][PDF] Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank

S Petersen, Z Raisi-Esabragh, Q Wang, V Codd - EBioMedicine, 2021 - qmro.qmul.ac.uk
Abstract (word count= 250) Background: Older age is the most powerful risk factor for
adverse coronavirus disease-19 (COVID-19) outcomes. It is uncertain whether leucocyte …
[HTML] sciencedirect.com

[HTML][HTML] Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank

Q Wang, V Codd, Z Raisi-Estabragh, C Musicha… - EBioMedicine, 2021 - Elsevier
Background Older age is the most powerful risk factor for adverse coronavirus disease-19
(COVID-19) outcomes. It is uncertain whether leucocyte telomere length (LTL), previously …

Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank

Q Wang, V Codd, Z Raisi-Estabragh… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Older age is the most powerful risk factor for adverse coronavirus disease-19
(COVID-19) outcomes. It is uncertain whether leucocyte telomere length (LTL), previously …

Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: a cohort study in UK Biobank

Q Wang, V Codd, Z Raisi-Estabragh, C Musicha… - …, 2021 - eprints.soton.ac.uk
Background Older age is the most powerful risk factor for adverse coronavirus disease-19
(COVID-19) outcomes. It is uncertain whether leucocyte telomere length (LTL), previously …

Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank

Q Wang, V Codd, Z Raisi-Estabragh, C Musicha… - …, 2021 - discovery.ucl.ac.uk
Background Older age is the most powerful risk factor for adverse coronavirus disease-19
(COVID-19) outcomes. It is uncertain whether leucocyte telomere length (LTL), previously …
[HTML] nih.gov

[HTML][HTML] Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank

Q Wang, V Codd, Z Raisi-Estabragh, C Musicha… - …, 2021 - ncbi.nlm.nih.gov
Background Older age is the most powerful risk factor for adverse coronavirus disease-19
(COVID-19) outcomes. It is uncertain whether leucocyte telomere length (LTL), previously …

Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank.

Q Wang, V Codd, Z Raisi-Estabragh, C Musicha… - Ebiomedicine, 2021 - europepmc.org
Background Older age is the most powerful risk factor for adverse coronavirus disease-19
(COVID-19) outcomes. It is uncertain whether leucocyte telomere length (LTL), previously …

Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank.

Q Wang, V Codd, Z Raisi-Estabragh, C Musicha… - Ebiomedicine, 2021 - europepmc.org
Background Older age is the most powerful risk factor for adverse coronavirus disease-19
(COVID-19) outcomes. It is uncertain whether leucocyte telomere length (LTL), previously …